This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Headache
  • /
  • The safety and efficacy of the 5-HT 1F receptor ag...
Journal

The safety and efficacy of the 5-HT 1F receptor agonist lasmiditan in the acute treatment of migraine.

Read time: 1 mins
Published:1st Sep 2017
Author: Raffaelli B, Israel H, Neeb L, Reuter U.
Availability: Pay for access, or by subscription
Ref.:Expert Opin Pharmacother. 2017;18(13):1409-1415.
DOI:10.1080/14656566.2017.1361406
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest